Jared Kehe
Co-Founder & Chief Scientific Officer Concerto Biociences
Dr. Jared Kehe is Co-Founder and Chief Scientific Officer of Concerto Biosciences, a company pioneering microbiome therapeutics through its proprietary kChip platform. Jared earned his PhD in biological engineering from MIT, where he developed high-throughput methods to study microbial communities. His work centers on designing microbial consortia that restore health by leveraging cooperative interactions among microbes. Concerto’s first product targets eczema, reflecting Jared’s vision to reframe microbes as allies in medicine.
Seminars
Thursday 29th January 2026
Mapping the Microbial World Through Massive Phenotypic Screens & Artificial Intelligence
2:00 pm
- Enabled by our MIT-developed combinatorial screening platform kChip, Concerto Biosciences’ ecological map of the microbial world incorporates 40+ million experimental measurements of microbial community behavior. This data trains our proprietary AI, kAI, to expand the map further still
- From this unique vantage, hundreds of robust, synergistic, and multifunctional microbe-based ingredient hits stand out in plain view. The first was ENS-002, a three-strain biotherapeutic that successfully completed Phase 1 clinical testing for atopic dermatitis
- We are now unleashing the full might of our platform and data in consumer health, beginning with deodorant and moving toward other applications in skin health and beyond
